Reducing inflammation before stem cell transplant in immune disorders
Treatments studied
Part of Immune system & allergy clinical trials.
This Phase 2 study tests medicines that calm inflammation before the first stem cell transplant. It aims to make transplant safer and more effective for people with certain inherited immune regulation or inflammatory conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are getting your first allogeneic stem cell transplant (for a specific immune regulation or autoinflammatory condition)
- Your inflammation tests are abnormal, or you have an immune pathway issue involving interferon-gamma (IFN-γ) with specific lab markers
- Your organs work well enough for transplant treatment (liver, kidneys, heart, and lungs must meet certain lab/scan thresholds)
- You can participate and follow the study plan, including required research blood tests and treatment steps
- You do NOT have an active, uncontrolled infection, have not had a prior transplant, and are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well a donor bone marrow (stem cell) transplant works for people with inherited immune system problems (called immune deficiencies). It’s for patients who haven’t improved with usual treatment or don’t have another good option.
This study tests whether an allogeneic stem cell (bone marrow) transplant can correct an inherited immune problem in people with severe primary immunodeficiencies. It may help reduce life-threatening infections and improve quality of life, depending on your overall health and donor match.
This trial is testing a more targeted way to deliver radiation before a stem cell transplant, aiming to reduce side effects while helping the new cells engraft. It includes two different radiation doses, one for first-time transplant patients and another for those who have relapsed after a prior transplant.
This Phase 2 study tests an immune-suppressing treatment for people with sickle cell disease or beta-thalassemia who are preparing for a stem cell transplant from a donor. It aims to help the transplant work better by changing the immune response.
This trial tests whether a gentler (reduced-intensity) conditioning treatment before a stem cell transplant works for non-cancer diseases. It uses specific donor stem cell matches and checks heart, lung, liver, and kidney function to help lower transplant stress while still aiming for benefit.
This Phase 2 trial tests a stem cell (bone marrow) transplant approach to restore bone marrow function and immune function in people with certain inherited immune problems. If you have one of these conditions and a suitable donor, the study may offer a path to rebuild blood and immune systems.
Hear when a new Primary Immune Regulatory Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.